Technology
Health
Biotechnology

IsoRay

$0.4672
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0022 (0.47%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell IsoRay and other stocks, options, ETFs, and crypto commission-free!

About

IsoRay, Inc., also called IsoRay, is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Read More Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Employees
38
Headquarters
Richland, Washington
Founded
1983
Market Cap
31.46M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
563.93K
High Today
$0.4882
Low Today
$0.46
Open Price
$0.4837
Volume
132.74K
52 Week High
$1.22
52 Week Low
$0.2691

Collections

Technology
Health
Biotechnology
Medical
Cancer Prevention
US
North America
Female CEOs

News

Yahoo FinanceMay 23

Imagine Owning IsoRay And Trying To Stomach The 81% Share Price Drop

IsoRay, Inc. (NYSEMKT:ISR) shareholders should be happy to see the share price up 19% in the last quarter. But will that repair the damage for the weary investors who have owned this stock as it declined over half a decade? Probably not. Indeed, the share price is down a whopping 81% in that time. So we don't gain too much confidence from the recent recovery. The real question is whether the business can leave its past behind and improve itself over the years ahead. While a drop like that is definitely a b...

118
Yahoo FinanceMay 9

IsoRay Reports Q3 Loss, Tops Revenue Estimates

IsoRay (ISR) delivered earnings and revenue surprises of 0.00% and 0.21%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

127
Yahoo FinanceMay 9

IsoRay: Fiscal 3Q Earnings Snapshot

RICHLAND, Wash. (AP) _ IsoRay Inc. (ISR) on Thursday reported a loss of $1.1 million in its fiscal third quarter. On a per-share basis, the Richland, Washington-based company said it had a loss of 2 cents. The isotope-based medical products maker posted revenue of $1.9 million in the period. In the final minutes of trading on Thursday, the company's shares hit 43 cents. A year ago, they were trading at 39 cents. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) usin...

16

Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
β€”
Actual
Expected Sep 24, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.